Mohd Athar
Overview
Explore the profile of Mohd Athar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Patel D, Athar M, Jha P
J Biomol Struct Dyn
. 2020 Nov;
40(7):3071-3081.
PMID: 33200683
Novel coronavirus SARS-CoV-2 has infected 18 million people with 700,000+ mortalities worldwide and this deadly numeric figure is rapidly rising. With very few success stories, the therapeutic targeting of this...
12.
Vora J, Athar M, Sinha S, Jha P, Shrivastava N
Curr HIV Res
. 2020 Jan;
18(2):132-141.
PMID: 31995010
Background: Despite intense efforts, AIDS is difficult to tackle by current anti-retroviral therapy (ART) due to its side effects; therefore, there is an urgent need to discover potential, multitarget and...
13.
Sharma V, Sharma A, Shah A, Shah P, Shrivastav P, Athar M
ACS Omega
. 2019 Oct;
4(14):15862-15872.
PMID: 31592456
A new class of blue light-emitting bowl-shaped mesogens with the thiacalix[4]arene core appended with 1,3,4-thiadiazole derivatives having peripheral alkoxy side chains have been synthesized and well characterized. The liquid crystalline...
14.
Sinha S, Patel S, Athar M, Vora J, Chhabria M, Jha P, et al.
Int J Biol Macromol
. 2019 Aug;
140:454-468.
PMID: 31404596
Triple-negative breast cancer (TNBC) is an aggressive disease exemplified by a poor prognosis, greater degrees of relapse, the absence of hormonal receptors for coherent utilization of targeted therapy, poor response...
15.
Vora J, Patel S, Athar M, Sinha S, Chhabria M, Jha P, et al.
J Biomol Struct Dyn
. 2019 May;
38(6):1726-1740.
PMID: 31057055
Dengue is a fast spreading mosquito borne viral disease that poses a serious threat to human health. Lack of therapeutic drugs and vaccines signify that more resources need to be...
16.
Kala C, Athar M, Kala S, Khan L, Jauhari R, Satsangi A
J Cytol
. 2019 Apr;
36(2):84-88.
PMID: 30992642
Objective: Triple negative breast cancer (TNBC), despite being the uncommon subtype, contributes a major portion to mortality and associated with poor prognosis. The purpose of this study was to evaluate...
17.
Athar M, Ranjan P, Jha P
J Mol Graph Model
. 2018 Jul;
84:160-165.
PMID: 29982033
Herein, we have presented the results of Density Functional Theory (DFT) based calculations of inclusion complexes of lapatinib and dasatinib with calix[n]arene macrocycles. A total of 48 calix [n]arene complexes...
18.
Ranjan P, Athar M, Jha P, Krishna K
Mol Divers
. 2018 Apr;
22(3):669-683.
PMID: 29611020
A quantitative structure-activity (QSAR) model has been developed for enriched tubulin inhibitors, which were retrieved from sequence similarity searches and applicability domain analysis. Using partial least square (PLS) method and...
19.
Lone M, Kumar S, Athar M, Jha P
J Theor Biol
. 2017 Dec;
439:14-23.
PMID: 29197513
Pharmacophore approaches are of central contour in drug discovery. However, the dependence of ligand-based pharmacophore model on appropriate training set molecules and typical use of apo-protein or single protein-ligand complex...
20.
Lone M, Manhas A, Athar M, Jha P
J Biomol Struct Dyn
. 2017 Aug;
36(11):2951-2965.
PMID: 28849732
In the present work, multiple pharmacophore-based virtual screening of the SPECS natural product database was carried out to identify novel inhibitors of the validated biological target, InhA. The pharmacophore models...